Navigation Links
GeneSeek Partners With Researchers to Combat E. coli
Date:8/22/2011

LANSING, Mich., Aug. 22, 2011 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) has announced that its GeneSeek subsidiary is a participant in USDA-funded research that seeks to better understand the role cattle genetics may play in food contamination by the pathogen E. coli O157:H7. GeneSeek is considered the leading commercial agricultural genetics laboratory in the United States.

Researchers have shown that while some cows have no E. coli O157:H7 in their systems, others present a greater risk for beef contamination by shedding higher concentrations of the pathogen in their feces. The existence of the pathogen does not cause illness in cattle, but E. coli O157:H7 is a significant cause of foodborne illness in humans.

"Researchers believe that if genetic markers for 'supershedders' of E. coli O157:H7, or animals that do not carry the microorganism, can be established, genetic and breeding programs can be developed to help minimize the risk that the pathogen presents to consumers of beef products," said James Herbert, Neogen's chairman and CEO. "Since E. coli O157:H7 was first identified as a major health risk, now more than 20 years ago, risk mitigation has focused on improving the beef industry's processing practices and product testing. We may now have the tools to work with the beef industry to minimize the problem at the source."

The research is being conducted by University of Nebraska-Lincoln scientists, in partnership with USDA's Meat Animal Research Center in Clay Center, Neb., and Lincoln-based GeneSeek. GeneSeek will perform genotyping on the cattle genetic samples.

"While epidemiologically oriented approaches have provided extensive information about the transmission patterns of the organism, they have essentially failed to come up with meaningful and effective pre-harvest interventions that work in beef pr
'/>"/>

SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Quanterix and STRATEC Announce Strategic Partnership
2. SynCo Bio Partners Expands the Class A Zone in its Aseptic Filling Facility
3. INC Research and Debiopharm Group(TM) Announce Strategic Partnership
4. Hitachi partnership brings new tools and electron microscope reference center to Edmonton
5. Emerson Ecologics Expands Partnership With Metagenics, Announces National Distribution Agreement
6. HCCS Partners with American Association of Critical Care Nurses (AACN) to Offer Nurse Training
7. Elsevier Strikes Exclusive eLearning Partnership with The Quality Group
8. ResearchDx and CompanDX Announce Strategic Partnership
9. The Pontifical Council for Culture and NeoStem Announce Steps Forward in their Partnership to Advance Adult Stem Cell Research
10. MKM Partners Hires Biotechnology/Specialty Pharmaceuticals Analyst
11. The Pittsburgh Life Sciences Greenhouse Announces Innovative Partnership With University of Pittsburgh Biomedical Engineering Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... October 30, 2014 Investor-Edge has ... (NYSE MKT: ONVO), Medivation Inc. (NASDAQ: MDVN ... Biologics Inc. (NYSE MKT: SYN), and Ironwood Pharmaceuticals Inc. ... be accessed at: http://investor-edge.com/register . On ... 4,549.23, down 0.33%, the Dow Jones Industrial Average declined ...
(Date:10/30/2014)... Chicago, Illinois (PRWEB) October 30, 2014 ... Regenerative and Cellular Medicine Showcase in Chicago, leading ... and Orthopedic Surgeon, Dr. Wade McKenna presented talks ... Effectiveness and Orthopedic Surgical Applications For Stem Cells. ... of amniotic membrane and the properties of AlphaGEMS ...
(Date:10/30/2014)... October 30, 2014 Spartan Bioscience announced ... RX CYP2C19 System . It detects CYP2C19 genetic mutations ... swab. , The Spartan RX CYP2C19 System is the ... been approved in Canada. Due to the system’s ease ... be used by healthcare professionals such as doctors, nurses, ...
(Date:10/30/2014)... CARLSBAD, Calif. , Oct. 30, 2014 Isis ... antisense therapeutics, today announced that management will present a company ... 2014 at 8:30 a.m. ET in Boston, MA. ... will be available on the "Investors & Media" section of ... available on the Isis website within 48 hours and will ...
Breaking Biology Technology:Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 4Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 5Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 2Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 3Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 4Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2
... WALTHAM, Mass., June 12 Repligen Corporation,(Nasdaq: RGEN ... fiscal,year 2008, ended March 31, 2008. Total revenue for ... $14,074,000 for fiscal year 2007,ended March 31, 2007, an ... consisted primarily of Protein A and SecreFlo(R) product revenue., ...
... Bulletin Board: RPTP), today announced that Ted Daley, President ... the 2008 BIO International Convention to be held June ... Diego, CA., Mr. Daley,s 15-minute corporate overview will ... in room 4 of the CNS/Neurology track., For ...
... Therapeutics, Inc.,(Nasdaq and MTA: CTIC) today announced that a ... newly issued 15% Convertible,Senior Notes due 2011, with an ... to purchase approximately 14.6 million shares of common stock,with ... transaction constitutes a partial exercise of a previously granted,warrant ...
Cached Biology Technology:Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results 2Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results 3Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results 4Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results 5Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results 6Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results 7Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results 8Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention 2Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention 3Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention 4Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor 2
(Date:10/30/2014)... German . ... to behave socially? This is one of the central ... studies assumed that it is almost impossible to control ... Planck Institute for Evolutionary Biology have now demonstrated that ... cooperative behaviour of others. However, the possibilities available to ...
(Date:10/30/2014)... North Carolina State University researchers have developed a suite ... between dogs and humans, which has applications in everything ... our pets. , "We,ve developed a platform for computer-mediated ... to new avenues for interpreting dogs, behavioral signals and ... Dr. David Roberts, an assistant professor of computer science ...
(Date:10/29/2014)... oil and gas production are well over recommended levels ... access journal Environmental Health . High levels of ... is the first to be based on community sampling ... be used to supplement official air-quality monitoring programs. , ... not readily flow to the surface. This is because ...
Breaking Biology News(10 mins):Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4New tech aims to improve communication between dogs and humans 2Air quality and unconventional oil and gas sites 2Air quality and unconventional oil and gas sites 3
... at Duke University and the U.S. Geological Survey (USGS) ... production in Arkansas. "Our results show no discernible ... gas drilling and hydraulic fracturing in this region," said ... Duke,s Nicholas School of the Environment. ...
... become stiff after middle age, a new study has revealed., ... compensate for the effects of obesity. But after middle age, ... body fat rises potentially increasing the risk of dying ... of body fat may be related to the total number ...
... emerged in China in February 2013, and is associated ... than 100 human cases of infection, including at least ... cases of infection were described in Hangzhou, Zhejiang Province, ... were similar to the previously reported cases in China. ...
Cached Biology News:Groundwater unaffected by shale gas production in Arkansas 2Body fat hardens arteries after middle age 2Evidence of host adaptation of avian-origin influenza A virus 2
...
Request Info...
Request Info...
... purification systems provide high speed purification of ... offer increased throughput and reproducible results. The ... mL and KingFisher 96, covering sample volumes ... consists of an instrument, specially designed plastics ...
Biology Products: